BackJapan Medical Dynamic Marketing Overview

Japan Medical Dynamic Marketing EBIT

Japan Medical Dynamic Marketing's EBIT is $-590M, below the sector sector average of $2.4T.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$509.96M
↓ 952.04% YoY

As of Sep 30, 2026

Annual EBIT (TTM)

-$590.47M
↑ 17.24% YoY

Trailing 12 months ending Sep 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Japan Medical Dynamic Marketing (JMDMF) FAQ

The latest EBIT for JMDMF is $-590M as of September 2026. That compares with $-710M in the prior-year period — up 17.2% year over year. That is below the sector sector average of $2.4T. Investors often review this figure alongside Japan Medical Dynamic Marketing's historical trend and sector peers before judging valuation or financial health.

Over the past year, JMDMF's EBIT moved from $-710M to $-590M — a 17.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Japan Medical Dynamic Marketing's operating scale or balance-sheet position.

Against its sector companies, JMDMF currently prints $-590M for EBIT, while the sector average sits near $2.4T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Japan Medical Dynamic Marketing's growth, margins, and balance sheet.

A EBIT figure of $-590M for JMDMF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.4T. Explore the charts below for those layers of context.

After noting JMDMF's EBIT ($-590M), review year-over-year change from $-710M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.